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Introduction
Small cell carcinoma of the bladder is a very rare tumor 
accounting for less than 1% of all bladder cancers (1). It is 
much aggressive than the commonly seen types of cancers of 
the bladder and urothelial carcinoma and is associated with 
poor prognosis. Clinically, it has similarities with urothelial 
carcinoma. Patients with small cell carcinoma of the bladder 
typically present with macroscopic hematuria and rarely with 
signs of bladder irritation. Additionally, rarely, there may be signs 
of abdominal pain and urinary system obstruction. Although 
there has not been a consensus on the treatment because of its 
rarity, multidisciplinary approach, including radical cystectomy 
(RC), chemotherapy and radiation therapy, is recommended to 
increase the chance of cure and life expectancy. 
Case Presentation
This study was retrospective and patient approval was obtained. 
An 86-year-old female patient presented to our clinic with a 
bladder mass which was detected incidentally. Ultrasonography 
showed a 14x9 mm hyperechoic, vascularized solid lesion in 
the right lateral wall protruding into the lumen. Complete 
transurethral resection of bladder tumor (TURBT) was performed. 
Pathologic examination revealed lamina propria-invasive small 
cell carcinoma which was not invading the muscularis propria 
(Figures 1, 2). Thoracoabdominal computed tomography showed 
primary bladder small cell carcinoma with no lung pathology. 
Although there was muscle tissue in the specimen in pathologic 
examination, restaging-TUR was performed in order to do 
better staging after four weeks and no tumor formation was 
recognized in the pathologic examination. Additional treatment 
options, such as RC and radiotherapy were recommended to 
the patient by giving information on the aggressiveness of the 
disease, however, the patient did not accept any treatment.  In 
the four-year follow-up of the patient who came to controls 
irregularly, no pathologic findings were detected in the control 
cystoscopies and systemic evaluations.
Abstract
Küçük hücreli kanser çoğunlukla akciğer orijinlidir. Fakat nadiren akciğer dışı organlarda da görülebilir. Mesanenin primer küçük hücreli karsinomu 
nadir görülen ve çoğunlukla metastazlarla seyreden agresif bir hastalıktır. Nadir görülmeleri nedeni ile tedavisinde fikir birliği sağlanmamış olsa da 
multimodal tedavi önerilmektedir. Bu çalışmada ek tedavileri kabul etmeyen, kas invaziv olmayan primer küçük hücreli mesane kanserli bir olgunun 
sadece transüretral rezeksiyon sonrası uzun dönem sonuçları sunulmuştur.
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Small cell carcinoma generally originates from the lungs. However, rarely, it could be observed in organs other than the lungs. Primary small cell 
carcinoma of the bladder is a rare and aggressive disease and it generally presents itself with metastasis. Although there has not been a consensus 
on the method of treatment for this rare disease, multimodal treatment is recommended. In this study, we present long-term results of transurethral 
resection in a patient with non-muscle-invasive primary small cell carcinoma who refused additional treatments. 
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Discussion
Small cell carcinoma of the bladder was first defined by Cramer 
et al. (2) in 1981. The ratio between male and female patients 
is 5/1 and it is seen commonly in the 6th decade of life (3). 
Pathologic diagnosis can generally be established via TURBT or 
immunohistochemical analysis of RC samples (4). Preoperative 
urine cytology may be useful for diagnosis, however this method 
has a low specificity (5). 
It is much aggressive than the commonly seen urothelial 
carcinomas of the bladder and has poor prognosis. Nearly 40% 
of patients with small cell carcinoma present at an advanced 
stage (6). In one study, it has been reported that 66% of patients 
had lymph node metastasis detected during RC (3). Our case 
belongs to the rare group of patients with non-muscle invasive 
disease followed up with re-TUR evaluation. The explanation for 
the absence of the expected aggressive features can be made 
based on this situation.
There is no standard treatment for small cell carcinoma of the 
bladder. Local treatment options are TURBT, RC and radiation 
therapy as for urothelial carcinoma. High recurrence and poor 
survival rates have been reported for the disease which cannot 
be controlled with only TURBT (7). According to the experiences 
of Mayo Clinic, if there is not any metastasis, RC should be 
performed for patients with bladder small cell carcinoma. 
Systemic chemotherapy should be planned for patients with 
metastasis. Chemotherapy following RC is not indicated for 
patients with stage 2 disease but is considered for those with 
stage 3 and 4 disease (8). Neoadjuvant chemotherapy and 
RC combination as multimodal therapy has been reported to 
provide longer survival when compared with RC alone (9). On 
the other hand, Cheng et al. (3) have reported that there was no 
difference in 5-year survival between patients treated with RC 
and those who received no treatment. 
In some selected patients with localized low-stage bladder small 
cell carcinoma, TURBT, radiotherapy and partial cystectomy can 
Figure 1. a) Small cell carcinoma of urinary bladder; tumor is composed of sheets and nests of atypical small cells (hematoxylin and eosin, 40x), b) Higher 
magnification of tumor cells with scant cytoplasm and hyperchromatic nucleus (hematoxylin and eosin, 200x)
Figure 2. a) Immunostaining for synaptophysin is diffusely positive (100x), b) Immunostaining for chromogranin A is diffusely positive (100x)
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be performed. RC is thought to be the best method to totally 
remove the mass, however, it only improves survival in patients 
with localized tumor (10). 
As a result, since it is an aggressive disease and is rarely seen, 
there is no standard treatment approach to the management 
of small cell carcinoma of the bladder. It is seen that in muscle 
invasive disease, there must be RC and in metastatic disease, 
multimodal treatment is required in the light of recent studies. 
However, in rare situations like our case, non-muscle-invasive 
disease may occur. There have not been many studies in the 
literature regarding non-muscle-invasive bladder small cell 
carcinoma. We believe that our study will be useful in the topic. 
However, it is obvious that large-scale studies are needed.
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